TVRD earnings
Tvardi Therapeutics (TVRD) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- TVRD beat EPS estimates in 4 of its last 11 reports.
TVRD earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | -0.48 | -0.57 | 15.89% | – |
| Q2 2026 | Aug 14, 2026 | -0.69 | -0.70 | 2.05% | – |
| Q1 2026 | May 8, 2026 | -0.73 | -0.65 | -12.31% | – |
| Q4 2025 | Mar 31, 2026 | -0.78 | -0.55 | -41.82% | – |
| Q3 2025 | Nov 13, 2025 | -0.59 | -0.83 | 28.92% | – |
| Q2 2025 | Aug 14, 2025 | -1.00 | -0.51 | -96.08% | – |
| Q1 2025 | May 13, 2025 | -3.22 | -0.58 | -450.43% | $2.57M |
| Q3 2024 | Nov 14, 2024 | -8.19 | -8.64 | 5.21% | $2.56M |
| Q2 2024 | Aug 14, 2024 | -13.17 | -9.86 | -33.52% | $991.00K |
| Q1 2024 | May 13, 2024 | -20.16 | -14.33 | -40.70% | $2.13M |
| Q4 2023 | Mar 4, 2024 | -21.24 | – | – | $3.00M |
| Q3 2023 | Nov 13, 2023 | -18.72 | – | – | $4.87M |
| Q2 2023 | Aug 7, 2023 | -20.88 | -19.38 | -7.74% | $6.93M |
| Q1 2023 | May 15, 2023 | -17.64 | – | – | $6.17M |
| Q4 2022 | Mar 6, 2023 | -20.32 | – | – | $3.26M |
| Q3 2022 | Nov 7, 2022 | -15.48 | – | – | $10.81M |